Biomanufacturing outsourcing trends
The biopharmaceutical industry is growing rapidly and one third of all drugs currently in development are biopharmaceutical products. There is sufficient capacity to manufacture these products. The major trends affecting capacity include the increase in protein expression levels, increased adoption of disposable technologies and the emergence of personalized medicine, which all lead to potentially smaller capacity requirements to meet market demand. This talk discusses how to select the right CMO given these industry trends.